{
  "id": 3857498,
  "title": "Tempus AI CEO Eric Lefkofsky sells $827,856 in stock",
  "url": "https://urgent.news/2026/08/28/tempus-ai-ceo-eric-lefkofsky-sells-827-856-in-stock",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-08-28T01:01:07.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/insider-trading-news/tempus-ai-ceo-eric-lefkofsky-sells-827856-in-stock-93CH-4880403"
  },
  "original_language": "en",
  "account": "Tempus AI CEO Eric Lefkofsky sold 11,848 shares of the company's Class A Common Stock, valued at $827,856, on August 25, 2026. The sale took place within a range of $69.83 to $70.58, a day when the stock's price reached $70.69. This move aligns with the company's 33% growth over the past six months, yet analysts consider TEM overvalued. Lefkofsky, who still directly holds 2,098,130 shares, also maintains significant indirect ownership in various entities, some of which his spouse manages. Tempus AI's recent Q2 2026 results revealed a 22% year-over-year revenue increase to $382.5 million, but fell short of forecasts. The company's acquisition of Ambry Genetics and the soon-to-be-acquired Personalis are expected to impact its future performance.",
  "summary": null,
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Investing.com",
        "title": "Cathie Wood’s ARK sells Tempus AI stock, buys Veracyte",
        "url": "https://urgent.news/2026/08/28/cathie-woods-ark-sells-tempus-ai-stock-buys-veracyte",
        "published": "2026-08-28T00:07:44.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}